Patents Assigned to GE Healthcare AS
  • Patent number: 9327212
    Abstract: A method for preparing a liquid flow having pre-defined characteristics by mixing liquid flows of at least two different component stock solutions with each other comprises the steps of determining a selected property value for one or more of the stock solutions by sensing, in a flow of each stock solution separately, at least one characteristic related to the property value for the stock solution, and based on the determined property value or values, mixing the stock solution flows in mixing ratios giving the desired mixed liquid flow. A system for carrying out the method comprises sensor means and a control unit, wherein the control unit is arranged to evaluate the characteristics sensed by the sensor means and provide relative ratios of stock solutions required to obtain a mixed liquid flow having the pre-defined characteristics.
    Type: Grant
    Filed: September 23, 2010
    Date of Patent: May 3, 2016
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Torbjorn Blank, Enrique Carredano, Karl Ekstrom, Jan-Erik Lynga, Roger Nordberg, Mike Peters, Gustav Rodrigo, Henrik Sandegren, Lisa Stack
  • Patent number: 9329112
    Abstract: A container holding, and a method of storing, freeze-dried biological samples. The container includes a chamber having an upper portion and a lower portion. The chamber includes a wall, and the lower portion of the chamber is fluidly connected to the upper portion of the chamber such that, when liquid is received at the upper portion, the received liquid can pass to and accumulate in the lower portion. Further, the freeze-dried material is located in the lower portion, and the container includes a physical structure in the form of a stop protruding inwards from the wall, the physical structure being for inhibiting the freeze-dried material from moving from the lower portion of the chamber to the upper portion of the chamber.
    Type: Grant
    Filed: January 25, 2012
    Date of Patent: May 3, 2016
    Assignee: GE HEALTHCARE UK LIMITED
    Inventors: Michael John Smith, Stevan Paul Tortorella
  • Patent number: 9322772
    Abstract: Disclosed is an apparatus for measuring the absorbance of a substance in a solution, comprising: i) a sample cell (30) of known path length (b) for containing said solution (S), said cell being transparent to light of a predefined wavelength spectrum; ii) plural LED's each being independently operable by means of a controller (25) each for emitting light, within said predefined wavelength spectrum, along a light path; iii) a band pass filter (22) in the light path; iv) a beam splitter (24) for dividing light from said source propagating along the path into a first portion and a second portion, said first portion being directable by the beam splitter toward a reference detector (42) and said second portion being directable into the cell (30); v) a reference detector (42) for detecting the intensity of said first portion of light directed by said beam splitter; and vi) a sample detector (40) for detecting the intensity of the second portion propagating from the cell; the apparatus allowing a sample in the cell
    Type: Grant
    Filed: May 30, 2013
    Date of Patent: April 26, 2016
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Hanno Ehring, Fredrik Lars Jarhede, Erik Ostlund
  • Patent number: 9316636
    Abstract: A method of determining kinetic parameters for a reversible molecular interaction between a ligand immobilized to a solid support surface and a binding partner to the ligand in solution, comprises sequentially, without intermediate regeneration or renewal of the immobilized ligand, flowing a plurality of fluid volumes containing different known concentrations of the binding partner over the solid support surface, monitoring the momentary amount of binding partner bound to the solid support surface related to time and solution concentration of binding partner and collecting the binding data, and determining the kinetic parameters by globally fitting a predetermined kinetic model for the interaction between the binding partner and the immobilized ligand to the collected binding data, which model allows for mass transport limitation at the solid support surface.
    Type: Grant
    Filed: October 25, 2012
    Date of Patent: April 19, 2016
    Assignee: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Robert Karlsson, Karl Andersson, Christina Wass
  • Patent number: 9314541
    Abstract: The present invention provides a method useful in the diagnosis and monitoring of cancer wherein there is an abnormal expression of PBR. The method of the invention is particularly useful in evaluating the severity of the cancer, e.g. PBR expression correlates with cell proliferation rates, metastatic potential, tumor aggressiveness, malignancy progression. The method of the invention can therefore be applied in the determination of likely disease progression and in making an associated prognosis. Furthermore, the method of the invention can find use in determining the likely success of certain therapeutic approaches, or in the evaluation of the efficacy of certain proposed new treatments.
    Type: Grant
    Filed: September 29, 2011
    Date of Patent: April 19, 2016
    Assignee: GE Healthcare Limited
    Inventor: Paul Alexander Jones
  • Patent number: 9316624
    Abstract: Disclosed herein is a chromatography system wherein a sensor, for example, a UV sensor, is tied to a continuously variable load pump in a feedback control loop, with an option to divert the feed stream back to the load vessel or reservoir or onto a second chromatography column, the disclosed chromatography system allowing a true feedback control across variable load rates, thereby adjusting chromatographic operating parameters, for example, variable load rates, to process conditions, while maximizing throughput.
    Type: Grant
    Filed: October 20, 2011
    Date of Patent: April 19, 2016
    Assignee: GE HEALTHCARE BIO-SCIENCES CORP.
    Inventor: Geoffrey L. Hodge
  • Patent number: 9308477
    Abstract: Embodiments of the invention relate to a syringeless filter device compressor for compressing one or more syringeless filter devices. Such syringeless filter devices are typically compressed entirely by hand; however, this may be uncomfortable and/or dangerous for the operator. In embodiments of the present invention, there is provided an apparatus comprising a holder for holding a plurality of syringeless filter devices in a two-dimensional array, and a compressor device. The compressor includes a pusher which can be moved by an actuator to compress the filtration devices held in the two-dimensional array. These features enable a compact compressor device for compressing syringeless filter devices, without the operator being in contact with the syringeless filter device during the compression process.
    Type: Grant
    Filed: June 26, 2012
    Date of Patent: April 12, 2016
    Assignee: GE HEALTHCARE UK LIMITED
    Inventors: David Gwyn Treharne, Stevan Paul Tortorella
  • Patent number: 9302202
    Abstract: A chromatography column having a longitudinal axis and comprising a column wall with a first end and a second end, a first end plate assembly removably connectable to said first end of the column wall, a second end plate assembly removably connectable to said second end of the column wall, wherein said first end plate assembly, said column wall and said second end plate assembly are arranged along the longitudinal axis of the column wherein the column wall, and/or first end plate assembly and/or second end plate assembly is/are rotatable about an axis of rotation wherein said axis of rotation is parallel to the longitudinal axis of said column and positioned outside the column.
    Type: Grant
    Filed: June 4, 2014
    Date of Patent: April 5, 2016
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Per Lofving, Mats Olsson, Sven Wounder, Jerker Persson
  • Patent number: 9296791
    Abstract: The present invention relates to an immunoglobulin-binding protein, wherein at least one asparagine residue has been mutated to an amino acid other than glutamine or aspartic acid, which mutation confers an increased chemical stability at pH-values of up to about 13-14 compared to the parental molecule. The protein can for example be derived from a protein capable of binding to other regions of the immunoglobulin molecule than the complementarity determining regions (CDR), such as protein A, and preferably the B-domain of Staphylococcal protein A. The invention also relates to a matrix for affinity separation, which comprises an immunoglobulin-binding protein as ligand coupled to a solid support, in which protein ligand at least one asparagine residue has been mutated to an amino acid other than glutamine.
    Type: Grant
    Filed: January 14, 2013
    Date of Patent: March 29, 2016
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Sophia Hober, Hans J. Johansson
  • Patent number: 9290549
    Abstract: The present invention relates to a chromatography ligand, which comprises Domain C from Staphylococcus protein A (SpA), or a functional fragment or variant thereof. The chromatography ligand presents an advantageous capability of withstanding harsh cleaning in place (CIP) conditions, and is capable of binding Fab fragments of antibodies. The ligand may be provided with a terminal coupling group, such as arginine or cysteine, to facilitate its coupling to an insoluble carrier such as beads or a membrane. The invention also relates to a process of using the ligand in isolation of antibodies, and to a purification protocol which may include washing steps and/or regeneration with alkali.
    Type: Grant
    Filed: January 27, 2014
    Date of Patent: March 22, 2016
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Martin Hall, Sture Larsson, Andreas Muranyi, Gustav Rodrigo, Jinyu Zou, Per-Mikael Aberg
  • Patent number: 9290372
    Abstract: A fluid distributor for uniformly distributing flow of a feed onto a chromatography column in a cost-effective way defines a distribution channel of generally conical shape between a solid back plate and a packed bed in the column, wherein the fluid distributor comprises at least two circular and/or annular fluid-permeable porous disks essentially filling the volume of the distribution channel.
    Type: Grant
    Filed: June 14, 2011
    Date of Patent: March 22, 2016
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Peter Bellqvist, Klaus Gebauer
  • Patent number: 9284554
    Abstract: The present disclosure provides a non-naturally occurring miRNA having a stem-loop structure comprising a scaffold derived from a first endogenous miRNA (e.g., miR-196a-2 or miR-204), a mature strand derived from a second endogenous miRNA, and a star strand sequence that is at least partially complementary to the mature strand sequence. The present disclosure also provides a non-naturally occurring miRNA having a stem-loop structure comprising a scaffold derived from an endogenous miRNA (e.g., miR-196a-2 or miR-204), a mature strand designed to be at least partially complementary to a target RNA, and a star strand sequence that is at least partially complementary to the mature strand sequence. The methods and compositions of the disclosure may be used to mediate gene silencing via the RNAi pathway.
    Type: Grant
    Filed: July 30, 2014
    Date of Patent: March 15, 2016
    Assignee: GE Healthcare Dharmacon, Inc.
    Inventors: Melissa Kelley, Amanda Birmingham, Jon Karpilow, Anastasia Khvorova, Kevin Sullivan
  • Patent number: 9284552
    Abstract: The present disclosure provides a method of modifying cells in order to enhance lentiviral titers, cell lines that are modified and modifying reagents. By mediating individual genes and combination thereof, lentiviral titers may be increased.
    Type: Grant
    Filed: April 2, 2013
    Date of Patent: March 15, 2016
    Assignee: GE Healthcare Dharmacon, Inc.
    Inventors: Katie Jansen Spayd, Jon Karpilow, John K. Wakefield
  • Patent number: 9278297
    Abstract: The present invention relates to a method for running ion exchange chromatography on a media comprising shell beads having an inner porous core and an outer shell, wherein the inner core is provided with ligands whose charge changes with pH and the shell is provided with charged ion exchange ligands, the method comprising the following steps: a) adsorbing sample molecules on the shell ligands at a first pH; b) causing a discharge of the inner core ligands at a second pH by addition of a buffer substance that is able to increase its charge having the same sign/type as that of the core ligands, which at the same time causes release of ions from the inner core ligands and thereby an increase in ionic strength that displaces the sample molecules from the shell ligands i.e. causes an elution.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: March 8, 2016
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Jan Bergstrom, Bo-Lennart Johansson
  • Patent number: 9279789
    Abstract: A chromatography column distribution system includes a set of first bed support ribs extending radially from an inner, first radial position near the centre of the plate to an outer radial position nearer to the periphery of the plate and at least one set of intermediate bed support ribs starting at an intermediate radial position and extending to an outer radial position nearer to the periphery of the plate. Channels are formed between adjacent bed support ribs. The desired local effective channel height varies in accordance with a predetermined formula from the first radial position to the outer radial position. The transverse cross-sectional areas of the ribs or the channels are adapted such that the actual local effective channel height is within 15% of the desired local effective channel height over portions of the distribution system situated between the first radial position and the outer radial position.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: March 8, 2016
    Assignee: GE Healthcare Bio-Sciences AB
    Inventor: Klaus Gebauer
  • Patent number: 9278916
    Abstract: The invention relates to a process for preparation of radiopharmaceutical precursors, and in particular protected amino acid derivatives which are used as precursors for production of radiolabeled amino acids for use in in vivo imaging procedures such as positron emission tomography (PET). Particularly, the invention relates to a process for preparation of a precursor of the [18F]-1-amino-3-fluorocyclobutanecarboxylic acid ([18F] FACBC) PET agent and particularly to the work-up process of this precursor removing generated salts from the intermediate composition.
    Type: Grant
    Filed: November 28, 2011
    Date of Patent: March 8, 2016
    Assignee: GE Healthcare Limited
    Inventors: Tom Christian Berg, Anne Nilsen
  • Patent number: 9278296
    Abstract: The present invention relates to methods for securing a distributor plate to a backing plate of a chromatography column without the need for releasable fixing means as screws or bolts. The invention also relates to chromatographic columns utilizing such methods. The method employs a negative pressure or vacuum that is generated internally within the column to affix the distributor to the backing plate.
    Type: Grant
    Filed: November 28, 2011
    Date of Patent: March 8, 2016
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Manoj Kumar Ramakrishna, Shashikanth Agnihotry
  • Publication number: 20160060617
    Abstract: The present invention relates to a method for storage and subsequent lysis of a sample in which the sample is immobilized on a solid support. The solid matrix is embedded with a low concentration of both a chaotropic salt and a surfactant which act synergistically to efficiently store and lyse a biological sample.
    Type: Application
    Filed: September 2, 2015
    Publication date: March 3, 2016
    Applicant: GE HEALTHCARE UK LIMITED
    Inventors: Hugh O'MALLEY, Barry JOHNSON
  • Patent number: 9272056
    Abstract: The invention relates to a dynamic nuclear polarisation method for producing hyperpolarised carboxylates of organic amines and amino compounds and compositions for use in that method. The DNP agent preferably is a stable oxygen-based, sulphur-based or carbon-based trityl radical. Optionally a paramagnetic metal ion is present.
    Type: Grant
    Filed: December 15, 2006
    Date of Patent: March 1, 2016
    Assignee: GE Healthcare AS
    Inventors: Mikkel Thaning, Karl Andreas Gram
  • Patent number: 9272251
    Abstract: The invention relates to an impeller for use in a bioreactor for growing adherent mammalian cells and/or a cell separator for adherent mammalian cells. The impeller of the invention is designed to efficiently and rapidly lift a bed of settled cells and microcarrier beads at low rotational speeds. Cell growth and concomitant yield is therefore improved by maintaining the culture in an environment of low shear force.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: March 1, 2016
    Assignee: GE HEALTHCARE UK LIMITED
    Inventors: Christopher Jones, Philip John Meyler, Rhys Evans